Канал: UC Berkeley SRP - Science for a Safer World

Session 2.1 Jean Van Buren

Session 2.1 Jean Van Buren

Session 1.1 David Sedlak

Session 1.1 David Sedlak

Session 1.3 Roger Brewer

Session 1.3 Roger Brewer

Session 3.5 Christopher Banks

Session 3.5 Christopher Banks

Session 3.3 Lida Chatzi

Session 3.3 Lida Chatzi

Session 3.2 Amy Padula

Session 3.2 Amy Padula

Session 3.1 Andres Cardenas

Session 3.1 Andres Cardenas

Session 2.4 Hailey Shingler

Session 2.4 Hailey Shingler

Session 2.3 Clare Pace

Session 2.3 Clare Pace

Session 2.2 Wendy Linck

Session 2.2 Wendy Linck

Session 2.1 Edmund Antell

Session 2.1 Edmund Antell

4.8. Future directions of the KCs – Lauren Zeise (Director, OEHHA)

4.8. Future directions of the KCs – Lauren Zeise (Director, OEHHA)

4.7. Panel discussion with Amy Kyle and Kathleen Durkin (UC Berkeley) and Tracey Woodruff (UCSF)

4.7. Panel discussion with Amy Kyle and Kathleen Durkin (UC Berkeley) and Tracey Woodruff (UCSF)

4.5. Applying the KCs approach for evidence screening and analysis - Xabier Arzuaga (US EPA)

4.5. Applying the KCs approach for evidence screening and analysis - Xabier Arzuaga (US EPA)

4.4. Applying the KCs in Decision making - Martha Sandy (OEHHA)

4.4. Applying the KCs in Decision making - Martha Sandy (OEHHA)

4.3. KCs of EDCs/Metabolic disruptors – Michele La Merrill (UC Davis)

4.3. KCs of EDCs/Metabolic disruptors – Michele La Merrill (UC Davis)

4.2. KCs of Immunotoxicants – Dori Germolec (NIEHS)

4.2. KCs of Immunotoxicants – Dori Germolec (NIEHS)

4.1. KCs of Hepatotoxicants – Dr. Ivan Rusyn (Texas A&M)

4.1. KCs of Hepatotoxicants – Dr. Ivan Rusyn (Texas A&M)

3.6. NAMs and In Silico approaches to the KCs - Dr. Kamel Mansouri (National Toxicology Program)

3.6. NAMs and In Silico approaches to the KCs - Dr. Kamel Mansouri (National Toxicology Program)

3.5. NAMs and In Silico approaches to the KCs - Prof. David Reif (N. Carolina State U.)

3.5. NAMs and In Silico approaches to the KCs - Prof. David Reif (N. Carolina State U.)

3.4. NAMs and In Silico approaches to the KCs - Dr. Raymond Tice (RTice Consulting)

3.4. NAMs and In Silico approaches to the KCs - Dr. Raymond Tice (RTice Consulting)

3.3. IARCs experience with the KCs - Dr. Mary Schubauer-Berigan (Head, IARC Monographs Programme)

3.3. IARCs experience with the KCs - Dr. Mary Schubauer-Berigan (Head, IARC Monographs Programme)

3.2. 10 years of the KCs of carcinogens – Dr. Kathryn Guyton (National Academies)

3.2. 10 years of the KCs of carcinogens – Dr. Kathryn Guyton (National Academies)

3.1. Introduction and the Birth of the KCs – Dr. Vincent Cogliano (OEHHA)

3.1. Introduction and the Birth of the KCs – Dr. Vincent Cogliano (OEHHA)

2.7. Comments Fenna Sille

2.7. Comments Fenna Sille

2.8. Summary and wrap up – Stephen Rappaport (UC Berkeley)

2.8. Summary and wrap up – Stephen Rappaport (UC Berkeley)

2.6. Exposomics – Rosemarie de la Rosa (UC Berkeley)

2.6. Exposomics – Rosemarie de la Rosa (UC Berkeley)

2.5. Childhood Cancer – Joseph Wiemels (USC) with comments from Cliona McHale

2.5. Childhood Cancer – Joseph Wiemels (USC) with comments from Cliona McHale

2.4. Comments from Luoping Zhang (former Superfund PI & 1990s alumnus

2.4. Comments from Luoping Zhang (former Superfund PI & 1990s alumnus

2.3. Comments from collaborators Nat Rothman and Qing Lan (NCI)

2.3. Comments from collaborators Nat Rothman and Qing Lan (NCI)

2.2. Video Comments by 1980s alumni Martha Sandy, Gunilla Ekstrom and Sarah Jewell

2.2. Video Comments by 1980s alumni Martha Sandy, Gunilla Ekstrom and Sarah Jewell

2.1. MPTP, Paraquat and Parkinson’s Disease – David Ross and Donato Di Monte

2.1. MPTP, Paraquat and Parkinson’s Disease – David Ross and Donato Di Monte

1.4. Overview of SRP Projects and Cores 2022-27 by Project and Core Leaders

1.4. Overview of SRP Projects and Cores 2022-27 by Project and Core Leaders

1.3. Opening remarks - Robert Spear

1.3. Opening remarks - Robert Spear

1.2. Opening remarks - William Suk

1.2. Opening remarks - William Suk

1.1. Welcome and Introduction - Martyn Smith and Michael Liu

1.1. Welcome and Introduction - Martyn Smith and Michael Liu

Martyn Smith KC Approach to Hazard ID Food Packaging Forum May 2020

Martyn Smith KC Approach to Hazard ID Food Packaging Forum May 2020